Seyed MohammadReza Hashemian

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 4 publications in August 2020
    All Publications
    Bar chart showing 45 publications over 10 distinct years, with a maximum of 17 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hashemian SM, Khoundabi B, Velayati AA. Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol. 2022 01; 102:107693. PMID: 34217670.
      Citations:    Fields:    Translation:Humans
    2. Mortaz E, Tabarsi P, Jamaati H, Dalil Roofchayee N, Dezfuli NK, Hashemian SM, Moniri A, Marjani M, Malekmohammad M, Mansouri D, Varahram M, Folkerts G, Adcock IM. Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727. PMID: 33968010.
      Citations: 2     Fields:    Translation:Humans
    3. Roshandel E, Sankanian G, Salimi M, Jalili A, Salari S, Sadeghi A, Hashemian SM, Moshari MR, Pirsalehi A, Hajifathali A. Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients. Transfus Apher Sci. 2021 Aug; 60(4):103141. PMID: 33896671.
      Citations: 1     Fields:    Translation:Humans
    4. Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947. PMID: 33607104.
      Citations: 12     Fields:    Translation:Humans
    5. Hashemian SM, Farhadi T, Velayati AA. A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Rev Anti Infect Ther. 2021 08; 19(8):1029-1037. PMID: 33372567.
      Citations: 4     Fields:    Translation:Humans
    6. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492. PMID: 33358260.
      Citations: 7     Fields:    Translation:HumansCells
    7. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Mortaz E, Tabarsi P, Marjani M, Malekmohammad M, Dastan F, Mortazavi SM, Sadr M, Idani E, Khoundabi B, Mohamadnia A, Abedini A, Kiani A, Moniri A, Nadji SA, Yassari F, Mokhber Dezfuli M, Pourabdollah M, Varahram M, Eshaghi F, Malekpour M, Velayati A. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299. PMID: 33959166.
      Citations: 1     
    8. Citations: 2     
    9. Baghaei P, Nadji SA, Marjani M, Moniri A, Hashemian SM, Sheikhzade H, Abtahian Z, Heshmatnia J, Abedini A, Jamaati H, Mansourafshar B, Ahmadi ZH, Mokhber Dezfuli M, Seifi S, Sadeghi M, Mirenayat MS, Yassari F, Lookzadeh S, Farzanegan B, Kiani A, Vasheghani M, Dastan F, Eslaminejad A, Malekmohammad M, Varahram M, Zali A, Tabarsi P, Velayati AA. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128. PMID: 33262799.
      Citations:    
    10. Rahmanzade R, Rahmanzadeh R, Hashemian SM, Tabarsi P. Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials. Front Public Health. 2020; 8:551889. PMID: 33014984.
      Citations: 4     Translation:Humans
    11. Moein ST, Hashemian SM, Tabarsi P, Doty RL. Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int Forum Allergy Rhinol. 2020 10; 10(10):1127-1135. PMID: 32761796.
      Citations: 26     Fields:    Translation:Humans
    12. Hashemian SM, Farhadi T, Velayati AA. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19. Drug Des Devel Ther. 2020; 14:3215-3222. PMID: 32821086.
      Citations: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    13. Rahmanzade R, Hashemian SM. Mini-surgical Percutaneous Dilatational Tracheostomy (msPDT): Our Experience during the COVID-19 Pandemic. Br J Surg. 2020 Sep; 107(10):e363. PMID: 32757206.
      Citations:    Fields:    Translation:HumansPHPublic Health
    14. Rahmanzade R, Rahmanzadeh R, Tabarsi P, Hashemian SM. Noninvasive Versus Invasive Ventilation in COVID-19: One Size Does Not Fit All! Anesth Analg. 2020 08; 131(2):e114-e115. PMID: 32366771.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    15. Hashemian SM, Khoundabi B, Tabarsi P. Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario. Tanaffos. 2020 Jul; 19(3):173-175. PMID: 33815536.
      Citations:    
    16. Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020 08; 10(8):944-950. PMID: 32301284.
      Citations: 243     Fields:    Translation:HumansCellsPHPublic Health
    17. Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688. PMID: 32544867.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    18. Rahmanzade R, Rahmanzadeh R, Hashemian SM. Respiratory Distress in Postanesthesia Care Unit: First Presentation of Coronavirus Disease 2019 in a 17-Year-Old Girl: A Case Report. A A Pract. 2020 May; 14(7):e01227. PMID: 32371823.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    19. Dastan F, Saffaei A, Mortazavi SM, Jamaati H, Adnani N, Samiee Roudi S, Kiani A, Abedini A, Hashemian SM. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341. PMID: 32353526.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    20. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36. PMID: 32922466.
      Citations: 15     
    21. Jamaati H, Dastan F, Esmaeili Dolabi S, Varahram M, Hashemian SM, Nasiri Rayeini S, Farzanegan B, Monjazebi F. COVID-19 in Iran: A model for Crisis Management and Current Experience. Iran J Pharm Res. 2020; 19(2):1-8. PMID: 33224206.
      Citations: 2     
    Hashemian's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (119)
    Explore
    _
    Co-Authors (80)
    Explore
    _
    Similar People (60)
    Explore
    _